The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBaronsmead 2vt Regulatory News (BMD)

Share Price Information for Baronsmead 2vt (BMD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 55.50
Bid: 54.00
Ask: 57.00
Change: 0.00 (0.00%)
Spread: 3.00 (5.556%)
Open: 55.50
High: 55.50
Low: 55.50
Prev. Close: 55.50
BMD Live PriceLast checked at -
Baronsmead Second Venture Trust is an Investment Trust

To achieve long-term investment returns for private investors by investing primarily in a diverse portfolio of UK growth businesses, whether unquoted or traded on AIM.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Intention to Utilise Over-allotment Facility

14 Mar 2024 13:00

RNS Number : 8959G
Baronsmead Second Venture Trust PLC
14 March 2024

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA, THE UNITED STATES OR ANY MEMBER STATE OF THE EEA (OTHER THAN ANY MEMBER STATE OF THE EEA WHERE THE COMPANY'S SECURITIES MAY BE LEGALLY MARKETED), OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE OR FORM PART OF ANY OFFER TO ISSUE OR SELL, OR ANY SOLICITATION OF ANY OFFER TO SUBSCRIBE OR PURCHASE, ANY INVESTMENTS IN ANY JURISDICTION.THIS ANNOUNCEMENT IS AN ADVERTISEMENT AND NOT A PROSPECTUS.

Baronsmead SECOND Venture Trust plc

LEI: 2138008D3WUMF6TW8C28

14 March 2024

Announcement of Intention to Utilise Over-allotment Facility and Offer Update

The Board of Baronsmead Second Venture Trust plc (the "Company") announced on 24 November 2023 that the Company, together with Baronsmead Venture Trust plc, had published a prospectus (the "Prospectus") in relation to offers for subscription to raise up to £30 million in aggregate with the discretion to utilise Over-allotment Facilities to raise up to a further £20 million in aggregate (the "Offers" and each an "Offer"). Full details of the Offer are contained in the Prospectus as supplemented by the supplementary prospectus dated 19 January 2024.

The Board is pleased to announce that, as of close of business on 13 March 2024, valid applications have been received for £12.25 million under the Company's Offer and therefore the initial amount is likely to be fully subscribed for shortly. On the basis of the deal pipeline, the Board has resolved that it is in the best interests of Shareholders to utilise the Over-allotment Facility and subscriptions will be accepted to raise up to an additional £10 million, subject to the terms of the Offer.

The first allotment of shares in respect of valid applications accepted by the Company took place on 26 January and the second allotment on 15 February 2024. The third allotment date is scheduled for 28 March 2024. As stated in the Prospectus, the fourth allotment will only take place if the Offer is not fully subscribed by 3 April 2024 and the Board decides to extend the period of the Offer.

All capitalised terms used and not defined herein shall have the same meaning as in the Prospectus.

For further information please contact:

Baronsmead VCT Investor Relations

020 7382 0999

baronsmeadvcts@greshamhouse.com

Important Information

This Announcement is an advertisement for the purposes of the Prospectus Regulation Rules of the UK Financial Conduct Authority ("FCA") and is not a prospectus. This Announcement does not constitute or form part of, and should not be construed as, an offer for sale or subscription of, or solicitation of any offer to subscribe for or to acquire, any ordinary shares in Baronsmead Venture Trust plc or Baronsmead Second Venture Trust plc (together the "Companies") in any jurisdiction, including in or into Australia, Canada, Japan, the Republic of South Africa, the United States or any member state of the EEA (other than any member state of the EEA where the Companies' securities may be lawfully marketed). Investors should not subscribe for or purchase any ordinary shares referred to in this Announcement except on the basis of information in the prospectus (the "Prospectus") in its final form, published on 24 November 2023 by Baronsmead Venture Trust plc and Baronsmead Second Venture Trust plc, together with the supplementary prospectus published on 19 January 2024 (the "Supplementary Prospectus"), in connection with the Offer. A copy of the Prospectus and Supplementary Prospectus is available for inspection, subject to certain access restrictions, from the Company's registered office, for viewing at the National Storage Mechanism at https://data.fca.org.uk/#/nsm/nationalstoragemechanism and on the Company's website (http://www.baronsmeadvcts.co.uk). Approval of the Prospectus and Supplementary Prospectus by the FCA should not be understood as an endorsement of the securities that are the subject of the Prospectus and Supplementary Prospectus. Potential investors are recommended to read the Prospectus and Supplementary Prospectus before making an investment decision in order to fully understand the potential risks and rewards associated with a decision to invest in the Companies' securities.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
UPDFZLFFZXLLBBL
Date   Source Headline
24th May 20175:00 pmRNSTransaction in Own Shares
24th May 20177:00 amRNSHalf-year Report
5th May 20174:00 pmRNSNet Asset Value(s)
18th Apr 20173:30 pmRNSNet Asset Value(s)
23rd Mar 20173:01 pmRNSResult of AGM
14th Mar 20179:16 amRNSDirector Declaration
6th Mar 201711:00 amRNSNet Asset Value(s)
2nd Mar 20177:00 amRNSDividend Declaration
6th Feb 201712:00 pmRNSNet Asset Value(s)
19th Jan 201710:00 amRNSNet Asset Value(s)
3rd Jan 20172:00 pmRNSTotal Voting Rights
14th Dec 20164:01 pmRNSTransaction in Own Shares
6th Dec 20164:00 pmRNSNet Asset Value(s)
30th Nov 20162:45 pmRNSIssue of Equity
28th Nov 20161:00 pmRNSNet Asset Value(s)
24th Nov 20162:30 pmRNSPublication of Supplementary Prospectus
17th Nov 20167:00 amRNSNet Asset Value(s)
17th Nov 20167:00 amRNSAnnual Financial Report
8th Nov 20164:36 pmRNSResult of General Meeting
17th Oct 20164:52 pmRNSMerger Update
14th Oct 20163:00 pmRNSNet Asset Value(s)
12th Oct 20163:19 pmRNSDirectorate Change
3rd Oct 20162:50 pmRNSTotal Voting Rights
29th Sep 20165:15 pmRNSTransaction in Own Shares
26th Sep 20164:00 pmRNSNet Asset Value(s)
6th Sep 20163:30 pmRNSNet Asset Value(s)
24th Aug 20167:00 amRNSDividend Declaration
19th Aug 201610:30 amRNSNet Asset Value(s)
19th Aug 20167:00 amRNSHalf-year Report
11th Aug 20165:30 pmRNSProposed Merger
9th Aug 20165:59 pmRNSChange of accounting reference date
1st Jul 201610:17 amRNSTotal Voting Rights
29th Jun 20164:56 pmRNSTransaction in Own Shares
6th Jun 20164:28 pmRNSNet Asset Value(s)
1st Jun 20164:24 pmRNSTransaction in Own Shares
24th May 20165:11 pmRNSNet Asset Value(s)
24th May 20164:53 pmRNSNet Asset Value(s)
12th May 201612:14 pmRNSDividend Declaration
19th Apr 20165:05 pmRNSResult of AGM
1st Apr 20163:16 pmRNSTotal Voting Rights
30th Mar 20165:48 pmRNSTransaction in Own Shares
15th Mar 20165:01 pmRNSChange of Name
15th Mar 20163:42 pmRNSIssue of Equity
11th Mar 20164:49 pmRNSIssue of Equity
10th Mar 20165:03 pmRNSPublication of Supplementary Prospectus
4th Mar 20164:57 pmRNSNet Asset Value(s)
3rd Mar 20165:12 pmRNSResult of General Meeting
2nd Mar 20162:43 pmRNSDirector Declaration
25th Feb 201611:03 amRNSDisclosure of Home Member State
24th Feb 201610:50 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.